| Value | ₹0.12 Cr |
|---|
BSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹39.60
- Market cap
- ₹68.52 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 7.6×Sector 46.1×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its shareholding pattern under Regulation 31(1)(c). The filing reports promoter, public and category-wise holdings without any transaction.
Shelter Pharma Preferential Issue
Shelter Pharma Ltd has allotted 4,65,000 equity shares via a preferential issue at ₹42.25 per share. This transaction resulted in a total capital infusion of ₹1.96 Crore.
- Value
- ₹1.96 Cr
Shelter Pharma Convertible Warrants
Shelter Pharma Limited approved the conversion of 465,000 warrants into equity shares for its promoter. This allotment follows the receipt of the remaining exercise price of Rs. 1.47 Crore.
- Value
- ₹1.47 Cr
Shelter Pharma Other Announcement
Shelter Pharma Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Shelter Pharma Management Change
Shelter Pharma Limited has regularized Ms. Vinita Shivraj Gadhavi as a Non-Executive Independent Director for a five-year term, following approval by shareholders at the 19th AGM.
Shelter Pharma Annual General Meeting
Shelter Pharma Limited conducted its 19th Annual General Meeting on September 29, 2026. Key agenda items included adopting financial statements and ratifying material related party transactions.
Other business update announcements
All →OnEMI Technology Solutions Business Update
OnEMI Technology Solutions (Kissht) disclosed its Key Performance Indicators for the quarter ended 30 September 2026. The KPIs, including those defined in its May 2026 prospectus, are published on the company website.
Hero MotoCorp Business Update
Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.
Cybele Industries Business Update
Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.
Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Vascon Engineers Business Update
Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.
- Value
- ₹72.00 Cr
- Execution
- 25 months
Meesho Business Update
Meesho's Q2 FY27 shareholders' letter reports NMV up 23% YoY to ₹12,911 crore. Festive timing moved the Mega Blockbuster Sale into Q3.